HIGHLIGHTS
- who: Lihua Wang from the Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, Zhejiang, China have published the Article: A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming, in the Journal: (JOURNAL)
- what: The authors demonstrated that the glucose blocking ability of WZ35 is one of its main anticancer mechanisms (Fig 6I).
- how: The multi-group data were compared via Kruskal-Wallis test. Together these results indicated that YAP protein was overexpressed in liver cancer cells and may serve as an important target for therapeutic intervention. A ROC calibration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.